<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Sci</journal-id><journal-id journal-id-type="iso-abbrev">Brain Sci</journal-id><journal-id journal-id-type="pmc-domain-id">2399</journal-id><journal-id journal-id-type="pmc-domain">brainsci</journal-id><journal-id journal-id-type="publisher-id">brainsci</journal-id><journal-title-group><journal-title>Brain Sciences</journal-title></journal-title-group><issn pub-type="epub">2076-3425</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11506346</article-id><article-id pub-id-type="pmcid-ver">PMC11506346.1</article-id><article-id pub-id-type="pmcaid">11506346</article-id><article-id pub-id-type="pmcaiid">11506346</article-id><article-id pub-id-type="pmid">39451989</article-id><article-id pub-id-type="doi">10.3390/brainsci14100975</article-id><article-id pub-id-type="publisher-id">brainsci-14-00975</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>White Matter Magnetic Resonance Diffusion Measures in Multiple Sclerosis with Overactive Bladder <xref rid="fn1-brainsci-14-00975" ref-type="author-notes">†</xref></article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0008-3702-2752</contrib-id><name name-style="western"><surname>Yang</surname><given-names initials="X">Xixi</given-names></name><xref rid="af1-brainsci-14-00975" ref-type="aff">1</xref><xref rid="af2-brainsci-14-00975" ref-type="aff">2</xref><xref rid="af3-brainsci-14-00975" ref-type="aff">3</xref><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="c1-brainsci-14-00975" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3024-0975</contrib-id><name name-style="western"><surname>Liechti</surname><given-names initials="MD">Martina D.</given-names></name><xref rid="af2-brainsci-14-00975" ref-type="aff">2</xref><xref rid="af3-brainsci-14-00975" ref-type="aff">3</xref><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="af5-brainsci-14-00975" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2443-8800</contrib-id><name name-style="western"><surname>Kanber</surname><given-names initials="B">Baris</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="af6-brainsci-14-00975" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sudre</surname><given-names initials="CH">Carole H.</given-names></name><xref rid="af6-brainsci-14-00975" ref-type="aff">6</xref><xref rid="af7-brainsci-14-00975" ref-type="aff">7</xref><xref rid="af8-brainsci-14-00975" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Castellazzi</surname><given-names initials="G">Gloria</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="af9-brainsci-14-00975" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jiaying</given-names></name><xref rid="af10-brainsci-14-00975" ref-type="aff">10</xref><xref rid="af11-brainsci-14-00975" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yiannakas</surname><given-names initials="MC">Marios C.</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gonzales</surname><given-names initials="G">Gwen</given-names></name><xref rid="af3-brainsci-14-00975" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prados</surname><given-names initials="F">Ferran</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="af6-brainsci-14-00975" ref-type="aff">6</xref><xref rid="af12-brainsci-14-00975" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4441-3750</contrib-id><name name-style="western"><surname>Toosy</surname><given-names initials="AT">Ahmed T.</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gandini Wheeler-Kingshott</surname><given-names initials="CAM">Claudia A. M.</given-names></name><xref rid="af4-brainsci-14-00975" ref-type="aff">4</xref><xref rid="af13-brainsci-14-00975" ref-type="aff">13</xref><xref rid="af14-brainsci-14-00975" ref-type="aff">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panicker</surname><given-names initials="JN">Jalesh N.</given-names></name><xref rid="af2-brainsci-14-00975" ref-type="aff">2</xref><xref rid="af3-brainsci-14-00975" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Chalah</surname><given-names initials="MA">Moussa Antoine</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Muthuraman</surname><given-names initials="M">Muthuraman</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-brainsci-14-00975"><label>1</label>Department of Neurology, Xuan Wu Hospital of Capital Medical University, Beijing 100053, China</aff><aff id="af2-brainsci-14-00975"><label>2</label>Department of Brain Repair and Rehabilitation, Faculty of Brain Sciences, Queen Square Institute of Neurology, University College London, London WC1E 6BT, UK; <email>martina.liechti@balgrist.ch</email> (M.D.L.); <email>j.panicker@ucl.ac.uk</email> (J.N.P.)</aff><aff id="af3-brainsci-14-00975"><label>3</label>Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK; <email>gwen.gonzales@uclh.nhs.uk</email></aff><aff id="af4-brainsci-14-00975"><label>4</label>NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, London WC1E 6BT, UK; <email>b.kanber@ucl.ac.uk</email> (B.K.); <email>gloria.castellazzi@unipv.it</email> (G.C.); <email>m.yiannakas@ucl.ac.uk</email> (M.C.Y.); <email>f.carrasco@ucl.ac.uk</email> (F.P.); <email>a.toosy@ucl.ac.uk</email> (A.T.T.); <email>c.wheeler-kingshott@ucl.ac.uk</email> (C.A.M.G.W.-K.)</aff><aff id="af5-brainsci-14-00975"><label>5</label>Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, 8006 Zürich, Switzerland</aff><aff id="af6-brainsci-14-00975"><label>6</label>Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London WC1E 6BT, UK; <email>c.sudre@ucl.ac.uk</email></aff><aff id="af7-brainsci-14-00975"><label>7</label>School of Biomedical Engineering and Imaging Sciences, King’s College London, London SE1 7EH, UK</aff><aff id="af8-brainsci-14-00975"><label>8</label>Dementia Research Centre, Institute of Neurology, University College London, London WC1E 6BT, UK</aff><aff id="af9-brainsci-14-00975"><label>9</label>Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy</aff><aff id="af10-brainsci-14-00975"><label>10</label>School of Artificial Intelligence, Beijing University of Post and Communications, Beijing 100876, China; <email>zjyei2006@gmail.com</email></aff><aff id="af11-brainsci-14-00975"><label>11</label>Department of Computer Science and Centre for Medical Image Computing, University College London, London WC1E 6BT, UK</aff><aff id="af12-brainsci-14-00975"><label>12</label>e-Health Centre, Universitat Oberta de Catalunya, 08018 Barcelona, Spain</aff><aff id="af13-brainsci-14-00975"><label>13</label>Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy</aff><aff id="af14-brainsci-14-00975"><label>14</label>Digital Neuroscience Centre, IRCCS Mondino Foundation, 27100 Pavia, Italy</aff><author-notes><corresp id="c1-brainsci-14-00975"><label>*</label>Correspondence: <email>xyang891@outlook.com</email>; Tel.: +86-137-5409-3891</corresp><fn id="fn1-brainsci-14-00975"><label>†</label><p>Part of Xixi Yang’s Ph.D. thesis.</p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2024</year></pub-date><volume>14</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">473615</issue-id><elocation-id>975</elocation-id><history><date date-type="received"><day>14</day><month>8</month><year>2024</year></date><date date-type="rev-recd"><day>22</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>9</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>26</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-26 11:25:37.737"><day>26</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>© 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="brainsci-14-00975.pdf"/><abstract><p>Background: Lower urinary tract (LUT) symptoms are reported in more than 80% of patients with multiple sclerosis (MS), most commonly an overactive bladder (OAB). The relationship between brain white matter (WM) changes in MS and OAB symptoms is poorly understood. Objectives: We aim to evaluate (i) microstructural WM differences across MS patients (pwMS) with OAB symptoms, patients without LUT symptoms, and healthy subjects using diffusion tensor imaging (DTI), and (ii) associations between clinical OAB symptom scores and DTI indices. Methods: Twenty-nine female pwMS [mean age (SD) 43.3 years (9.4)], including seventeen with OAB [mean age (SD) 46.1 years (8.6)] and nine without LUT symptoms [mean age (SD) 37.5 years (8.9)], and fourteen healthy controls (HCs) [mean age (SD) 48.5 years (20)] were scanned in a 3T MRI with a DTI protocol. Additionally, clinical scans were performed for WM lesion segmentation. Group differences in fractional anisotropy (FA) were evaluated using tract-based spatial statistics. The Urinary Symptom Profile questionnaire assessed OAB severity. Results: A statistically significant reduction in FA (<italic toggle="yes">p</italic> = 0.004) was identified in microstructural WM in pwMS, compared with HCs. An inverse correlation was found between FA in frontal and parietal WM lobes and OAB scores (<italic toggle="yes">p</italic> = 0.021) in pwMS. Areas of lower FA, although this did not reach statistical significance, were found in both frontal lobes and the rest of the non-dominant hemisphere in pwMS with OAB compared with pwMS without LUT symptoms (<italic toggle="yes">p</italic> = 0.072). Conclusions: This study identified that lesions affecting different WM tracts in MS can result in OAB symptoms and demonstrated the role of the WM in the neural control of LUT functions. By using DTI, the association between OAB symptom severity and WM changes were identified, adding knowledge to the current LUT working model. As MS is predominantly a WM disease, these findings suggest that regional WM involvement, including of the anterior corona radiata, anterior thalamic radiation, superior longitudinal fasciculus, and superior frontal-occipital fasciculus and a non-dominant prevalence in WM, can result in OAB symptoms. OAB symptoms in MS correlate with anisotropy changes in different white matter tracts as demonstrated by DTI. Structural impairment in WM tracts plays an important role in LUT symptoms in MS.</p></abstract><kwd-group><kwd>multiple sclerosis (MS)</kwd><kwd>overactive bladder (OAB) symptoms</kwd><kwd>white matter (WM)</kwd><kwd>diffusion tensor imaging (DTI)</kwd><kwd>tract-based spatial statistics (TBSS)</kwd></kwd-group><funding-group><award-group><funding-source>UK Multiple Sclerosis Society</funding-source><award-id>Ref 19</award-id></award-group><award-group><funding-source>Swiss National Science Foundation</funding-source><award-id>P2EZP3_148749</award-id><award-id>P300PB_161087</award-id></award-group><award-group><funding-source>UCL and the Neuroscience Center Zürich</funding-source></award-group><award-group><funding-source>UK Multiple Sclerosis Society</funding-source></award-group><award-group><funding-source>NIHR UCLH BRC</funding-source></award-group><award-group><funding-source>Alzheimer’s Society Junior Fellowship</funding-source><award-id>AS-JF-17-011</award-id></award-group><award-group><funding-source>ECTRIMS Postdoctoral Research Fellowship Program grant</funding-source></award-group><award-group><funding-source>China Scholarship Council</funding-source></award-group><award-group><funding-source>non-clinical postdoctoral Guarantors of Brain fellowship</funding-source></award-group><award-group><funding-source>NIHR Biomedical Research Centre at UCL/UCLH</funding-source></award-group><award-group><funding-source>Higher Education Funding Council for England (HEFCE)</funding-source></award-group><award-group><funding-source>ISRT</funding-source></award-group><award-group><funding-source>Wings for Life</funding-source><award-id>169111</award-id></award-group><award-group><funding-source>Craig H. Neilsen Foundation</funding-source></award-group><award-group><funding-source>MS Society</funding-source><award-id>77</award-id></award-group><award-group><funding-source>Horizon2020</funding-source><award-id>634541</award-id></award-group><award-group><funding-source>BRC</funding-source><award-id>BRC704/CAP/CGW</award-id></award-group><award-group><funding-source>MRC</funding-source><award-id>PGL21/10079</award-id></award-group><award-group><funding-source>Ataxia UK, and Rosetrees Trust</funding-source><award-id>PGL22/100041</award-id><award-id>PGL21/10079</award-id></award-group><award-group><funding-source>United Kingdom’s Department of Health NIHR Biomedical Research Centres funding scheme</funding-source></award-group><funding-statement>This work was supported by the UK Multiple Sclerosis Society (Grant Ref 19). M.D.L. received funding from the Swiss National Science Foundation (fellowship P2EZP3_148749 and P300PB_161087), joint research funding from UCL and the Neuroscience Center Zürich, and from the UK Multiple Sclerosis Society. B.K. is part-funded by the NIHR UCLH BRC. C.H.S. is supported by an Alzheimer’s Society Junior Fellowship (AS-JF-17-011). G.C. is supported by an ECTRIMS Postdoctoral Research Fellowship Program grant. J.Z. is supported by the China Scholarship Council. F.P.C. has a non-clinical postdoctoral Guarantors of Brain fellowship. F.P.C. and B.K. are funded by the NIHR Biomedical Research Centre at UCL/UCLH. A.T.T. is supported by the Higher Education Funding Council for England (HEFCE). C.A.M.G.W.-K. received funding during this study from ISRT, Wings for Life, and the Craig H. Neilsen Foundation (the INSPIRED study), from the MS Society (#77), Wings for Life (#169111), Horizon2020 (CDS-QUAMRI, #634541), and is currently funded by BRC (#BRC704/CAP/CGW), MRC (#MR/S026088/1), Ataxia UK, and Rosetrees Trust (#PGL22/100041 and #PGL21/10079). The work was undertaken at UCLH/UCL Institute of Neurology and JNP is supported in part by funding from the United Kingdom’s Department of Health NIHR Biomedical Research Centres funding scheme.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-brainsci-14-00975"><title>1. Introduction</title><p>Lower urinary tract (LUT) symptoms are reported in more than 80% of multiple sclerosis (MS) patients (pwMS), significantly impacting quality of life [<xref rid="B1-brainsci-14-00975" ref-type="bibr">1</xref>,<xref rid="B2-brainsci-14-00975" ref-type="bibr">2</xref>]. The commonest LUT symptoms reported are storage or overactive bladder symptoms (OAB; defined as urinary urgency, with or without urgency urinary incontinence and usually associated with daytime urinary frequency and nocturia) [<xref rid="B3-brainsci-14-00975" ref-type="bibr">3</xref>] and voiding symptoms (including slow and/or intermittent stream, splitting or spraying, hesitancy, straining, and terminal dribble) [<xref rid="B4-brainsci-14-00975" ref-type="bibr">4</xref>,<xref rid="B5-brainsci-14-00975" ref-type="bibr">5</xref>]. The pattern of LUT symptoms is influenced by the site of lesions in the central nervous system [<xref rid="B6-brainsci-14-00975" ref-type="bibr">6</xref>].</p><p>In recent years, magnetic resonance imaging (MRI), in particular functional MRI (fMRI), has provided considerable insight into the central neural control of LUT functions [<xref rid="B6-brainsci-14-00975" ref-type="bibr">6</xref>,<xref rid="B7-brainsci-14-00975" ref-type="bibr">7</xref>]. There are a number of cortical and subcortical regions identified that consistently show changes in neural activity during bladder-specific tasks [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>,<xref rid="B9-brainsci-14-00975" ref-type="bibr">9</xref>]. Insight has been gained into the role of these different regions such as the thalamus, insula, anterior cingulate cortex, and medial and lateral prefrontal cortex (mPFC and lPFC) during bladder filling and emptying, and distinct patterns of activation and deactivation are seen in cohorts of healthy subjects and in patients with idiopathic OAB [<xref rid="B10-brainsci-14-00975" ref-type="bibr">10</xref>]. These findings have led to a network model, which proposes cerebral circuits for perception of bladder fullness and urgency [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>]. In MS, activation and deactivation have been seen in cortical and subcortical grey matter (GM) regions following a bladder infusion task [<xref rid="B9-brainsci-14-00975" ref-type="bibr">9</xref>,<xref rid="B11-brainsci-14-00975" ref-type="bibr">11</xref>]. These studies focus on GM changes; however, MS is overwhelmingly a white matter (WM) disease and the nature of the relationship between WM lesions and LUT symptoms is unknown. Studies using MRI showed more WM changes in MS, compared with healthy people, not only due to the WM lesions but also in the normal-appearing WM [<xref rid="B12-brainsci-14-00975" ref-type="bibr">12</xref>]. Regarding specific functions, microstructural WM changes were found to be widespread, interrupting structural pathways connecting remote brain regions and thus playing an important role in changes in cognitive function [<xref rid="B13-brainsci-14-00975" ref-type="bibr">13</xref>]. In early MS, a stronger structural-to-functional coupling was identified, suggesting that the ability of the brain to reorganise functional networks could diminish at later stages of the disease and could no longer compensate the MS-related structural damage [<xref rid="B14-brainsci-14-00975" ref-type="bibr">14</xref>,<xref rid="B15-brainsci-14-00975" ref-type="bibr">15</xref>]. Studies exploring treatment effects in GM for LUT symptoms in MS had proven difficult without the assessment of the degree of WM abnormalities between the relevant GM regions [<xref rid="B16-brainsci-14-00975" ref-type="bibr">16</xref>]. Therefore, it is important to investigate not only the changes in GM in MS but also the WM impairment. In patients with other WM disorders, namely small vessel disease, structural MRI studies suggest that the anterior thalamic radiation and the superior longitudinal fasciculus are specifically important for LUT functions and are involved in continence control [<xref rid="B10-brainsci-14-00975" ref-type="bibr">10</xref>,<xref rid="B17-brainsci-14-00975" ref-type="bibr">17</xref>], and WM hyperintensity (WMH) in the anterior corona radiata and the cingulate gyrus is reported to predict urinary incontinence and degree of bother [<xref rid="B18-brainsci-14-00975" ref-type="bibr">18</xref>].</p><p>Diffusion-weighted imaging (DWI) evaluates the microscopic random thermal motion of water, and is used to provide microstructural information on WM in neurological diseases [<xref rid="B19-brainsci-14-00975" ref-type="bibr">19</xref>,<xref rid="B20-brainsci-14-00975" ref-type="bibr">20</xref>,<xref rid="B21-brainsci-14-00975" ref-type="bibr">21</xref>,<xref rid="B22-brainsci-14-00975" ref-type="bibr">22</xref>]. Along WM tracts, water diffusion is more rapid, while it is slower in the direction perpendicular to the fibres [<xref rid="B23-brainsci-14-00975" ref-type="bibr">23</xref>]. This property is captured—to some extent—by diffusion tensor imaging (DTI), from which it is possible to obtain several scalar indices (fractional anisotropy, FA; mean diffusivity, MD; axial diffusivity, AD; radial diffusivity, RD) commonly used to characterise tissue microstructure properties [<xref rid="B24-brainsci-14-00975" ref-type="bibr">24</xref>]. FA is the most frequently used index in clinical studies for its better sensitivity to tissue microstructure property changes and has also been shown to be reduced in the WM of pwMS, compared to healthy people [<xref rid="B25-brainsci-14-00975" ref-type="bibr">25</xref>,<xref rid="B26-brainsci-14-00975" ref-type="bibr">26</xref>,<xref rid="B27-brainsci-14-00975" ref-type="bibr">27</xref>]. </p><p>In this study, we aim to use DTI to explore the microstructural WM changes in a cohort of pwMS and compare differences in patients with and without LUT symptoms using voxel-wise analysis, and correlations between DTI measures (FA) and clinical scores of OAB, without a priori assumption on the location of the expected changes.</p></sec><sec id="sec2-brainsci-14-00975"><title>2. Materials and Methods</title><sec id="sec2dot1-brainsci-14-00975"><title>2.1. Subjects</title><p>Women with a diagnosis of MS according to the McDonald criteria [<xref rid="B28-brainsci-14-00975" ref-type="bibr">28</xref>], with and without LUT symptoms, attending the out-patient clinic at a tertiary-level teaching hospital, were included between September 2015 and August 2017. Individuals who were pregnant or breast feeding, having any contraindications for MRI, had a previous history of craniocerebral injuries or surgeries, had any other known neurological disorders, expercognitive impairment assessed by a Mini-Mental State Examination (MMSE &lt; 23) [<xref rid="B29-brainsci-14-00975" ref-type="bibr">29</xref>], scored &gt; 6.5 on the Expanded Disability Status Scale (EDSS) [<xref rid="B30-brainsci-14-00975" ref-type="bibr">30</xref>], reported an MS relapse in the previous 3 months, were undergoing treatment for LUT symptoms within the previous 6 months, had evidence for additional active urological disease or anatomical anomalies of the urogenital system during assessments, had undergone surgeries to the urogenital tract which could influence LUT symptoms, or had metabolic disease were excluded (see <xref rid="app1-brainsci-14-00975" ref-type="app">Appendix A</xref>). Considering that the 2017 revision of the McDonald criteria [<xref rid="B31-brainsci-14-00975" ref-type="bibr">31</xref>] was published during the study, all recruited MS patients were screened based on the 2017 McDonald criteria to make sure that the included MS patients fulfilled the new diagnostic criteria. Healthy controls (HCs) without diagnosed neurological disease or LUT symptoms were recruited. The study protocols were approved The Joint Medical Ethics Committee of the National Hospital for Neurology and Neurosurgery and the Institute of Neurology, London (protocol No. is 13/0523; REC reference is 14/LO/1636) and all subjects were fully informed and consented before participating.</p></sec><sec id="sec2dot2-brainsci-14-00975"><title>2.2. Clinical Assessments</title><p>The neurological and uro-neurological examinations were performed for pwMS and HCs (JNP and AT). LUT symptoms were evaluated using a standard three-day bladder diary and a validated questionnaire, the Urinary Symptom Profile (USP) [<xref rid="B32-brainsci-14-00975" ref-type="bibr">32</xref>]. The USP questionnaire is a comprehensive evaluation of LUT symptoms that assesses three domains: OAB, stress urinary incontinence, and low stream [<xref rid="B32-brainsci-14-00975" ref-type="bibr">32</xref>]. Patients were classed as either having no LUT symptoms (MS-no-LUTS) or having OAB (MS-OAB) according to their history of LUT symptoms, the three-day bladder diary, and the USP questionnaire’s OAB sub-score. </p></sec><sec id="sec2dot3-brainsci-14-00975"><title>2.3. Imaging Acquisition</title><p>MRI scanning was performed using a 3.0 Tesla scanner (Philips Achieva, Philips Medical Systems, Best, The Netherlands). Proton density (PD) and T2-weighted images were acquired in the axial–oblique plane parallel to the anterior–posterior callosal line using the following parameters: Time Echo (TE)1/TE2 = 19/85 ms; Time Repetition (TR) = 3500 ms; Field Of View (FOV) 240 × 180 mm<sup>2</sup>; NEX = 1, voxel size = 1 × 1 × 3 mm<sup>3</sup>; 50 slices; and scan time = 4:01 min. DTI was also performed in the axial–oblique plane, with 32 distributed diffusion encoding directions (b = 0 and b = 1000 s/mm<sup>2</sup>) and the following parameters: TE = 92 ms; TR = 9714 ms; FOV 248 × 248 mm<sup>2</sup>; NEX = 1; voxel size = 2 × 2 × 2 mm<sup>3</sup>; 70 slices; and scan time = 6:46 min.</p></sec><sec id="sec2dot4-brainsci-14-00975"><title>2.4. Lesion Masking</title><p>WM lesions were identified on both PD and T2-weighted images and manually segmented on PD images using Jim 6.0 (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.xinapse.com/Manual/">http://www.xinapse.com/Manual/</uri>, accessed on 1 March 2017). The lesion volume was then calculated and further used as a covariate in the statistical analysis.</p></sec><sec id="sec2dot5-brainsci-14-00975"><title>2.5. MRI Image Processing and Tract-Based Spatial Statistics (TBSS) Analysis</title><p>Image processing and tract-based spatial statistics (TBSS) were performed using the FMRIB Software Library (FSL, Oxford, UK, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl">https://fsl.fmrib.ox.ac.uk/fsl</uri>, accessed on 1 September 2017). The diffusion-weighted images were corrected for eddy current-induced distortions and movements using FSL [<xref rid="B33-brainsci-14-00975" ref-type="bibr">33</xref>]. DTI fitting and calculation of FA maps were performed using the NiftyFit toolbox [<xref rid="B34-brainsci-14-00975" ref-type="bibr">34</xref>].</p><p>The standard TBSS pipeline was applied to the data: all FA images were non-linearly registered [<xref rid="B35-brainsci-14-00975" ref-type="bibr">35</xref>] to the FMRIB58_FA template in MNI152 space (MNI, McConnell Brain Imaging Centre), and then skeletonised and concatenated into a 4D file (skeletonized). The WM skeleton was created with an FA threshold of 0.2. The JHU ICBM-DTI-81 White-Matter atlas and the JHU White-Matter Tractography atlas were used to identify the regions of interest emerging from the statistical analysis of the skeletonised FA of pwMS subgroups and HCs [<xref rid="B36-brainsci-14-00975" ref-type="bibr">36</xref>,<xref rid="B37-brainsci-14-00975" ref-type="bibr">37</xref>].</p></sec><sec id="sec2dot6-brainsci-14-00975"><title>2.6. Statistical Analysis</title><p>Descriptive statistics of age, EDSS, lesion volume, disease duration, and the OAB sub-score from the USP questionnaire (USP-OAB) were expressed as means and standard deviations and all variables were checked for skewness and presence of outliers. SPSS version 24 was used for the statistical analysis; a <italic toggle="yes">p</italic> value &lt; 0.05 was considered statistically significant, and a <italic toggle="yes">p</italic> value &lt; 0.1 was considered a favourable statistical trend.</p><p>The design matrix and contrast files were created by the General Linear Model (GLM) tool (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/GLM">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/GLM</uri>, accessed on 1 December 2017) and passed to the Randomise tool (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Randomise">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Randomise</uri>, accessed on 1 December 2017) for nonparametric permutation inference (5000 permutations). The Threshold-Free Cluster Enhancement (TFCE) option was adopted for all tests in Randomise (<italic toggle="yes">p</italic> &lt; 0.05 as statistical significant; <italic toggle="yes">p</italic> &lt; 0.1 as statistical trend) [<xref rid="B38-brainsci-14-00975" ref-type="bibr">38</xref>].</p><p>Differences between the pwMS and HCs were analysed for internal validation, adjusting for age. Comparisons between the two pwMS sub-groups (MS-no-LUTS and MS-OAB) were performed to identify WM changes potentially responsible for LUT symptoms in MS, adjusting for age and EDSS. Correlation analysis (Spearman correlation coefficient, 2-tailed) was performed to explore any associations between diffusion measures (FA) and clinical scores of OAB (USP-OAB) in pwMS. All regressors added to the regression model were mean-centred across all subjects.</p></sec><sec id="sec2dot7-brainsci-14-00975"><title>2.7. Bullseye Representation</title><p>Differences in the distribution and frequency of WM changes were plotted in a bullseye plot of WM regions [<xref rid="B39-brainsci-14-00975" ref-type="bibr">39</xref>]. The regional representation was based on the division of the WM and deep GM volume into sectors (representing the lobes) and radial regions (representing the distance from the ventricles) [<xref rid="B39-brainsci-14-00975" ref-type="bibr">39</xref>]. Aggregation of cortical regions obtained from the Geodesic Information Flow (GIF) parcellation algorithm [<xref rid="B40-brainsci-14-00975" ref-type="bibr">40</xref>] applied to the brain in MNI space was used to obtain cortical lobes (or deep GM regions), and WM voxels were allocated to the closest cortical lobe. The lobes were illustrated as FRONT (frontal lobe), PAR (parietal lobe), TEMP (temporal lobe), OCC (occipital lobe), and BGIT (the basal ganglia, thalami, and infratentorial regions from both sides) [<xref rid="B39-brainsci-14-00975" ref-type="bibr">39</xref>]. Radially, the application of the Laplace equation between the ventricular and cortical surfaces enabled the creation of a normalised distance measure that was divided into four equal parts providing the four equidistant radial layers [<xref rid="B39-brainsci-14-00975" ref-type="bibr">39</xref>]. Overall, this systematic division of the volume of interest resulted in thirty-six regions (four layers and nine lobar separations) [<xref rid="B39-brainsci-14-00975" ref-type="bibr">39</xref>].</p><p>This regional division of the WM volume allows for a local representation of the whole-brain results. In this study, distribution plots reflect the ratio between the number of voxels of interest (significant values) located in the specific region and the overall number of significant voxels, while the frequency plots were drawn as the ratio between number of significant voxels in a given region and volume of this region. The lesion volume frequency plots represent the ratio between the median and the interquartile range (IQR, measuring statistical dispersion) of lesion volume in the given region and the volume of that region.</p></sec></sec><sec sec-type="results" id="sec3-brainsci-14-00975"><title>3. Results</title><sec id="sec3dot1-brainsci-14-00975"><title>3.1. Subsection</title><sec sec-type="subjects" id="sec3dot1dot1-brainsci-14-00975"><title>3.1.1. Participants</title><p>Thirty right-handed women pwMS and fourteen women HCs fulfilling the recruitment/inclusion criteria participated in this study. Three pwMS reporting predominantly voiding problems were excluded from the data analysis between MS-no-LUTS and MS-OAB, and one patient was excluded after a subsequent change in diagnosis. Demographic characteristics are presented in <xref rid="brainsci-14-00975-t001" ref-type="table">Table 1</xref>. </p></sec><sec id="sec3dot1dot2-brainsci-14-00975"><title>3.1.2. Group Difference Analysis</title><p>Differences in the FA of the WM skeleton between the three groups were statistically significant (<xref rid="brainsci-14-00975-t002" ref-type="table">Table 2</xref>). The WM skeleton and significant results of group difference from TBSS are illustrated in the images in <xref rid="brainsci-14-00975-f001" ref-type="fig">Figure 1</xref>. Compared with the HC group, FA was significantly reduced in the MS group after adjusting for age, in voxels, across whole-brain WM regions, especially the corpus callosum. Compared with MS-no-LUTS, there was a significant FA reduction in the MS-OAB group after adjusting for EDSS (<italic toggle="yes">p</italic> = 0.047), and a trend for significance after adjusting for age and EDSS (<italic toggle="yes">p</italic> = 0.072) (<xref rid="brainsci-14-00975-t002" ref-type="table">Table 2</xref>). A greater lesion volume was seen in the MS-OAB group (<xref rid="brainsci-14-00975-f002" ref-type="fig">Figure 2</xref>).</p></sec><sec id="sec3dot1dot3-brainsci-14-00975"><title>3.1.3. Correlation Analysis </title><p><xref rid="brainsci-14-00975-t003" ref-type="table">Table 3</xref> illustrates the results of the correlation analysis and relative significance. When all the participants were analysed as a single group (n = 43), negative correlations were observed between FA and age (<italic toggle="yes">p</italic> = 0.018) and USP-OAB sub-score (<italic toggle="yes">p</italic> = 0.001). In the pwMS cohort (n = 26), significant negative correlations were observed between FA and age (<italic toggle="yes">p</italic> = 0.008) and the USP-OAB sub-score (<italic toggle="yes">p</italic> = 0.021). </p></sec><sec id="sec3dot1dot4-brainsci-14-00975"><title>3.1.4. WM Tract Analysis Using TBSS</title><p>Voxels in the corpus callosum, anterior corona radiata bilaterally, right anterior thalamic radiation, superior longitudinal fasciculus bilaterally, and right inferior longitudinal fasciculus showed a trend for significance in group difference in FA between MS-no-LUTS and MS-OAB, after adjusting for age and EDSS score (<xref rid="brainsci-14-00975-f001" ref-type="fig">Figure 1</xref>a). A significant correlation was seen between decreasing FA and increasing USP-OAB sub-score in voxels in the corpus callosum, anterior corona radiata bilaterally, superior corona radiata bilaterally, superior longitudinal fasciculus bilaterally, inferior longitudinal fasciculus bilaterally, and inferior fronto-occipital fasciculus bilaterally (<xref rid="brainsci-14-00975-f001" ref-type="fig">Figure 1</xref>b).</p><p>Bullseye plots show the lobar involvement of group difference and correlation analysis, respectively (<xref rid="brainsci-14-00975-f003" ref-type="fig">Figure 3</xref>).</p></sec></sec></sec><sec sec-type="discussion" id="sec4-brainsci-14-00975"><title>4. Discussion</title><p>Current understanding of the central neural network controlling LUT functions is centred around different GM cortical and subcortical regions such as the thalamus, insula, anterior cingulate cortex, mPFC, and lPFC [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>]. Findings in the neural network that correlate with LUT dysfunction have been demonstrated in pwMS. In MS, the WM lesion distribution correlates with the clinical manifestations and disease course [<xref rid="B42-brainsci-14-00975" ref-type="bibr">42</xref>]. The role of the connecting WM tracts in the regulation of LUT functions remains speculative [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>] and this study aimed to explore the microstructural WM changes in association with OAB symptoms in pwMS. In this study, we explored differences in WM microstructure in MS-OAB and MS-no-LUTS by evaluating changes in FA using diffusion-weighted MRI. We identified FA reduction in the pwMS cohort compared with HC, which was consistent with the previous literature [<xref rid="B25-brainsci-14-00975" ref-type="bibr">25</xref>,<xref rid="B43-brainsci-14-00975" ref-type="bibr">43</xref>]. There were two salient findings that demonstrate the relationship between changes in WM tracts and the occurrence of OAB symptoms. </p><p>Reductions in FA were observed in the MS-OAB group compared with MS-no-LUTS (<xref rid="brainsci-14-00975-t002" ref-type="table">Table 2</xref>) in regions including the corpus callosum, anterior corona radiata, anterior thalamic radiation, superior longitudinal fasciculus, and inferior longitudinal fasciculus, and the reductions in FA were consistent with previous studies [<xref rid="B17-brainsci-14-00975" ref-type="bibr">17</xref>,<xref rid="B18-brainsci-14-00975" ref-type="bibr">18</xref>]. These tracts were particularly susceptible in pwMS and correlated with LUT symptoms. Among the identified tracts, WM changes in the corpus callosum have been widely reported in pwMS, accounting for various LUT functions; WM changes in the anterior thalamic radiation, superior longitudinal fasciculus, and inferior longitudinal fasciculus had also been reported in pwMS, accounting for cognitive functions [<xref rid="B25-brainsci-14-00975" ref-type="bibr">25</xref>]. After controlling for age and EDSS, taken as a measure of overall motor and functional disability, a significant FA reduction was seen in WM tracts in MS-OAB, suggesting that involvement of these WM tracts results in LUT symptoms. Taking into consideration the working model of LUT control based on previous studies evaluating GM structures [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>], the findings from the present study suggested the presence of a suprapontine WM circuit supporting the LUT functional network, connecting the different GM regions involving the thalamus, insula, anterior cingulate cortex, and prefrontal cortex. In addition, WM studies assessing WMH in a cohort of elderly community-dwelling women from Kuchel et al. and Tadic et al. speculated the involvement of the cingulum, anterior corona radiata, anterior thalamic radiation, superior longitudinal fasciculus, and superior frontal-occipital fasciculus for urinary incontinence [<xref rid="B17-brainsci-14-00975" ref-type="bibr">17</xref>,<xref rid="B18-brainsci-14-00975" ref-type="bibr">18</xref>]. Our study confirmed the presence of FA reductions in these specific WM tracts as well using an established quantitative MRI technique and statistical analysis of the whole WM skeleton.</p><p>WM changes were particularly observed in the frontal WM as expected. Bladder function, including attention and information processing speed in integrating the awareness of bladder filling and voiding, was associated with cognitive performance, pointing out a strong overlap of the brain structures involved [<xref rid="B44-brainsci-14-00975" ref-type="bibr">44</xref>]. Regions in frontal WM were demonstrated to correlate with information processing speed and attention [<xref rid="B15-brainsci-14-00975" ref-type="bibr">15</xref>]. The role of the prefrontal lobe in continence was established through seminal work by Andrew and Nathan [<xref rid="B45-brainsci-14-00975" ref-type="bibr">45</xref>], and the orbitofrontal or lPFC has been demonstrated to have extensive connections with the limbic system, including the insula, which was found to be the homeostatic afferent area projecting the sensation of bladder filling [<xref rid="B46-brainsci-14-00975" ref-type="bibr">46</xref>,<xref rid="B47-brainsci-14-00975" ref-type="bibr">47</xref>], and the anterior cingulate cortex, which mediated LUT functions together with the supplementary motor area through the perception of the sensation of urgency and resultant contraction of the urethral sphincter [<xref rid="B48-brainsci-14-00975" ref-type="bibr">48</xref>]. Moreover, differences were seen to extend beyond the frontal WM, and rather unexpectedly greater WM changes were seen in the entire non-dominant (right) hemisphere in the MS-OAB group (<xref rid="brainsci-14-00975-f003" ref-type="fig">Figure 3</xref>a). Previous studies evaluating the cerebral control network of LUT functions had similarly demonstrated BOLD signal changes preferentially affecting the non-dominant insula and right lPFC [<xref rid="B8-brainsci-14-00975" ref-type="bibr">8</xref>]. There was a non-dominant hemisphere prevalence presented in the median lesion volume plot (<xref rid="brainsci-14-00975-f002" ref-type="fig">Figure 2</xref>b), and lesions of the right hemisphere would be consistent with the expected findings in the literature [<xref rid="B18-brainsci-14-00975" ref-type="bibr">18</xref>]. Previous studies demonstrated a correlation between interoceptive awareness and right GM regions, including the right insula and right thalamus [<xref rid="B49-brainsci-14-00975" ref-type="bibr">49</xref>,<xref rid="B50-brainsci-14-00975" ref-type="bibr">50</xref>,<xref rid="B51-brainsci-14-00975" ref-type="bibr">51</xref>], and the findings from this study suggest that WM changes in the right hemisphere can also result in changes in visceral functions manifesting with LUT symptoms. </p><p>A negative correlation was observed between FA and the USP-OAB sub-score, suggesting that a lower FA was associated with more severe OAB symptoms (<xref rid="brainsci-14-00975-t003" ref-type="table">Table 3</xref>). Considering that an important role for WM changes in the anterior corona radiata was shown to predict urinary incontinence severity in elderly women with small vessel disease [<xref rid="B10-brainsci-14-00975" ref-type="bibr">10</xref>,<xref rid="B18-brainsci-14-00975" ref-type="bibr">18</xref>], this study confirmed the importance of this tract in the neural control of LUT functions; moreover, our results suggested that there were additional WM tracts that, when affected by microstructure alterations, could contribute to LUT dysfunction (OAB) in neurological diseases (MS). It would be pertinent for future studies to confirm these findings in terms of the correlation with specific symptoms of OAB, such as urgency and frequency, and in other neurological disorders, such as small vessel disease.</p><p>There are some limitations of this study. In the group difference analysis, only a trend towards a significantly reduced FA (<italic toggle="yes">p</italic> = 0.072) was observed in MS-OAB compared with MS-no-LUTS, after adjusting for age and EDSS. The small sample size and the differences in group size were likely to have been factors affecting the group difference results, though LUT symptoms are reported in 80% of pwMS and therefore a cohort of pwMS without LUT symptoms is uncommon and difficult to recruit. Secondly, LUT symptoms presented heterogeneously in MS, and the cohort we investigated was only a subset of a more complex group. There could have been a selection bias to select only female patients (EDSS ≤ 6.5) in our study, but this could be interpreted as an intended benefit of having a more uniform study population. Additionally, only the suprapontine subcortical WM changes were evaluated in this study and LUT symptoms can also arise from spinal cord lesions [<xref rid="B1-brainsci-14-00975" ref-type="bibr">1</xref>], which were not assessed. Lastly, the EDSS score used for measuring MS disability includes a bladder functional symptom score which may account for a decrease in significance when regressing EDSS for LUT symptoms. Greater correlation with involvement of WM in the non-dominant hemisphere needs to be evaluated in further studies to understand whether this contributes to the mechanisms of LUT dysfunction only in MS or whether it is a salient characteristic in LUT dysfunction.</p></sec><sec sec-type="conclusions" id="sec5-brainsci-14-00975"><title>5. Conclusions</title><p>The findings of this study demonstrate an association between more severe OAB symptoms and more microstructural WM abnormalities in both frontal lobes and the rest of the non-dominant hemisphere in pwMS, using diffusion MRI. WM lesions affecting specific WM tracts, including the corpus callosum, anterior corona radiata bilaterally, superior corona radiata bilaterally, superior longitudinal fasciculus bilaterally, inferior longitudinal fasciculus bilaterally, and inferior fronto-occipital fasciculus bilaterally, can result in more severe OAB symptoms. Our findings suggest that the WM tracts play an important role in the neural control of LUT functions.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Jeremy Chataway, Olga Ciccarelli, Mahreen Pakzad, and the MS team for their help and advice on data acquisition and analysis.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher’s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, J.N.P. and C.A.M.G.W.-K.; methodology, J.N.P., C.A.M.G.W.-K., M.C.Y. and F.P.; software, F.P., B.K. and C.H.S.; validation, X.Y., J.N.P. and C.A.M.G.W.-K.; formal analysis, X.Y., M.D.L., B.K., C.H.S., G.C., J.Z., F.P., A.T.T., C.A.M.G.W.-K. and J.N.P.; investigation, X.Y., M.D.L., M.C.Y., G.G., A.T.T. and J.N.P.; resources, J.N.P. and C.A.M.G.W.-K.; data curation, X.Y. and M.D.L.; writing—original draft preparation, X.Y.; writing—review and editing, X.Y., J.N.P., C.A.M.G.W.-K., A.T.T., J.Z. and M.C.Y.; supervision, J.N.P. and C.A.M.G.W.-K.; project administration, J.N.P. and C.A.M.G.W.-K.; funding acquisition, J.N.P., C.A.M.G.W.-K. and M.D.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was approved by The Joint Medical Ethics Committee of the National Hospital for Neurology and Neurosurgery and the Institute of Neurology, London (protocol No. is 13/0523; REC reference is 14/LO/1636) on 6 May 2016.</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent has been obtained from the patients to publish this paper.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author. Data are not publicly available due to ethical reasons.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><app-group><app id="app1-brainsci-14-00975"><title>Appendix A. Summary of Inclusion and Exclusion Criteria of This Study</title><array orientation="portrait"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Inclusion and Exclusion Criteria</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inclusion Criteria<list list-type="simple"><list-item><label>-</label><p>At least 18 years old</p></list-item><list-item><label>-</label><p>Able to understand the patient information sheet</p></list-item><list-item><label>-</label><p>Written informed consent to take part and follow the requirements of the protocol</p></list-item></list>For patients with MS: <list list-type="simple"><list-item><label>-</label><p>Diagnosis according to the McDonald criteria</p></list-item><list-item><label>-</label><p>Having a score on the Kurtzke Expanded Disability Status Scale ≤ 6.5</p></list-item><list-item><label>-</label><p>Free of relapses in the previous 3 months</p></list-item></list>For patients with idiopathic LUT symptoms:<list list-type="simple"><list-item><label>-</label><p>Routine clinical assessments excluding a neurological cause for symptoms</p></list-item></list>For patients with predominant storage symptoms:<list list-type="simple"><list-item><label>-</label><p>Urinary urgency (≥2 episodes per week), urinary frequency (&gt;8/24 h), and/or incontinence</p></list-item><list-item><label>-</label><p>Post-void residual volume &lt; 150 mL</p></list-item></list>For patients with predominant voiding symptoms:<list list-type="simple"><list-item><label>-</label><p>Hesitancy, slow or intermittent stream, straining to void, or relying on catheterisation for bladder emptying</p></list-item></list>For patients with mixed storage and voiding LUT symptoms: <list list-type="simple"><list-item><label>-</label><p>Urgency (≥2 episodes per week), urinary frequency (&gt;8/24 h), and/or incontinence</p></list-item><list-item><label>-</label><p>Hesitancy, slow or intermittent stream, straining to void, or relying on catheterisation for bladder emptying</p></list-item></list>For patients with neurological disease without LUT symptoms:<list list-type="simple"><list-item><label>-</label><p>No episodes of urinary urgency or incontinence; urinary frequency &lt; 8/24 h</p></list-item><list-item><label>-</label><p>No voiding symptoms; post-void residual volume &lt; 150 mL</p></list-item></list>For healthy subjects: <list list-type="simple"><list-item><label>-</label><p>Good mental and physical health</p></list-item><list-item><label>-</label><p>Normal functioning of the LUT</p></list-item><list-item><label>-</label><p>No episodes of urinary urgency or incontinence; urinary frequency &lt; 8/24 h</p></list-item><list-item><label>-</label><p>No malignancy or previous surgery of the LUT or genitalia</p></list-item><list-item><label>-</label><p>No previous spine or pelvic surgery</p></list-item></list></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exclusion Criteria<list list-type="simple"><list-item><label>-</label><p>Pregnant, breast feeding, or planning to become pregnant during the study duration</p></list-item><list-item><label>-</label><p>Any contraindications to having MRI (e.g., ferromagnetic implants), as assessed by the NMR unit’s MRI safety checklist</p></list-item><list-item><label>-</label><p>Craniocerebral injuries or surgeries</p></list-item><list-item><label>-</label><p>Known neurological disease other than that being used for the investigation</p></list-item><list-item><label>-</label><p>Cognitive impairment, as assessed by a Mini-mental State Examination (MMSE) score &lt; 23</p></list-item><list-item><label>-</label><p>Presence of additional active urological disease that might explain LUT symptoms</p></list-item><list-item><label>-</label><p>Surgery of the LUT or genitalia within the last year or that is related to the LUT symptoms, as per the discretion of the investigator</p></list-item><list-item><label>-</label><p>Any anatomical anomaly of LUT/genitalia</p></list-item><list-item><label>-</label><p>Active LUT malignancy or metabolic disease, as per the discretion of the investigator</p></list-item><list-item><label>-</label><p>For the functional brain imaging part, additional exclusion criteria apply:
<list list-type="simple"><list-item><label>-</label><p>Receiving concomitant treatment for LUTS</p></list-item><list-item><label>-</label><p>Received tibial nerve stimulation or intravesical Botulinum A toxin injections within the previous six months</p></list-item><list-item><label>-</label><p>If on an antimuscarinic medication, unwilling to discontinue for at least 5 days prior to having MRI assessment</p></list-item></list></p></list-item></list></td></tr></tbody></array></app></app-group><ref-list><title>References</title><ref id="B1-brainsci-14-00975"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phé</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chartier-Kastler</surname><given-names>E.</given-names></name><name name-style="western"><surname>Panicker</surname><given-names>J.N.</given-names></name></person-group><article-title>Management of neurogenic bladder in patients with multiple sclerosis</article-title><source>Nat. Rev. Urol.</source><year>2016</year><volume>13</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1038/nrurol.2016.53</pub-id><pub-id pub-id-type="pmid">27030526</pub-id></element-citation></ref><ref id="B2-brainsci-14-00975"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seddone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Marturano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bientinesi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lucchini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bassi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mirabella</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nociti</surname><given-names>V.</given-names></name></person-group><article-title>Lower urinary tract disorders in multiple sclerosis patients: Prevalence, clinical features, and response to treatments</article-title><source>Neurourol. Urodyn.</source><year>2021</year><volume>40</volume><fpage>1500</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1002/nau.24687</pub-id><pub-id pub-id-type="pmid">34082481</pub-id><pub-id pub-id-type="pmcid">PMC8361667</pub-id></element-citation></ref><ref id="B3-brainsci-14-00975"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wein</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Rovner</surname><given-names>E.S.</given-names></name></person-group><article-title>Definition and Epidemiology of Overactive Bladder</article-title><source>Urology</source><year>2002</year><volume>60</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/S0090-4295(02)01784-3</pub-id><pub-id pub-id-type="pmid">12493342</pub-id></element-citation></ref><ref id="B4-brainsci-14-00975"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abrams</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cardozo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fall</surname><given-names>M.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rosier</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ulmsten</surname><given-names>U.</given-names></name><name name-style="western"><surname>Van Kerrebroeck</surname><given-names>P.</given-names></name><name name-style="western"><surname>Victor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wein</surname><given-names>A.</given-names></name></person-group><article-title>The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society</article-title><source>Urology</source><year>2003</year><volume>61</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/S0090-4295(02)02243-4</pub-id><pub-id pub-id-type="pmid">12559262</pub-id></element-citation></ref><ref id="B5-brainsci-14-00975"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tornic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Panicker</surname><given-names>J.N.</given-names></name></person-group><article-title>The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis</article-title><source>Curr. Neurol. Neurosci. Rep.</source><year>2018</year><volume>18</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1007/s11910-018-0857-z</pub-id><pub-id pub-id-type="pmid">29956001</pub-id><pub-id pub-id-type="pmcid">PMC6022518</pub-id></element-citation></ref><ref id="B6-brainsci-14-00975"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panicker</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Kessler</surname><given-names>T.M.</given-names></name></person-group><article-title>Lower urinary tract dysfunction in the neurological patient: Clinical assessment and management</article-title><source>Lancet Neurol.</source><year>2015</year><volume>14</volume><fpage>720</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(15)00070-8</pub-id><pub-id pub-id-type="pmid">26067125</pub-id></element-citation></ref><ref id="B7-brainsci-14-00975"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>Z.-L.</given-names></name><name name-style="western"><surname>Senol</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z.-D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Neural circuit control of innate behaviors</article-title><source>Sci. China Life Sci.</source><year>2022</year><volume>65</volume><fpage>466</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1007/s11427-021-2043-2</pub-id><pub-id pub-id-type="pmid">34985643</pub-id></element-citation></ref><ref id="B8-brainsci-14-00975"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Griffiths</surname><given-names>D.</given-names></name></person-group><source>Functional Imaging of Structures Involved in Neural Control of the Lower Urinary Tract</source><edition>1st ed.</edition><publisher-name>Elsevier B.V.</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2015</year><volume>Volume 130</volume><fpage>121</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-63247-0.00007-9</pub-id><pub-id pub-id-type="pmid">26003241</pub-id></element-citation></ref><ref id="B9-brainsci-14-00975"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehnert</surname><given-names>U.</given-names></name><name name-style="western"><surname>van der Lely</surname><given-names>S.</given-names></name><name name-style="western"><surname>Seif</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leitner</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liechti</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Michels</surname><given-names>L.</given-names></name></person-group><article-title>Neuroimaging in Neuro-Urology</article-title><source>Eur. Urol. Focus.</source><year>2020</year><volume>6</volume><fpage>826</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2019.12.006</pub-id><pub-id pub-id-type="pmid">32122815</pub-id></element-citation></ref><ref id="B10-brainsci-14-00975"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>R.P.E.</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Silva-Ramos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Verdelho</surname><given-names>A.</given-names></name></person-group><article-title>Age-related white matter hyperintensities and overactive bladder: A systematic review</article-title><source>Neurourol. Urodyn.</source><year>2023</year><volume>42</volume><fpage>1088</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1002/nau.25174</pub-id><pub-id pub-id-type="pmid">36971037</pub-id></element-citation></ref><ref id="B11-brainsci-14-00975"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khavari</surname><given-names>R.</given-names></name><name name-style="western"><surname>Karmonik</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>S.</given-names></name><name name-style="western"><surname>Boone</surname><given-names>T.</given-names></name><name name-style="western"><surname>R</surname><given-names>K.</given-names></name><name name-style="western"><surname>S</surname><given-names>E.</given-names></name><name name-style="western"><surname>R</surname><given-names>P.</given-names></name><name name-style="western"><surname>K</surname><given-names>W.</given-names></name><name name-style="western"><surname>T</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis</article-title><source>J. Urol.</source><year>2017</year><volume>197</volume><fpage>438</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2016.09.077</pub-id><pub-id pub-id-type="pmid">27664581</pub-id><pub-id pub-id-type="pmcid">PMC5497828</pub-id></element-citation></ref><ref id="B12-brainsci-14-00975"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caranova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Batista</surname><given-names>S.</given-names></name><name name-style="western"><surname>Castelo-Branco</surname><given-names>M.</given-names></name><name name-style="western"><surname>Duarte</surname><given-names>J.V.</given-names></name></person-group><article-title>A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging</article-title><source>Magn. Reson. Imaging</source><year>2023</year><volume>104</volume><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2023.09.010</pub-id><pub-id pub-id-type="pmid">37775062</pub-id></element-citation></ref><ref id="B13-brainsci-14-00975"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meijer</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Steenwijk</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Douw</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schoonheim</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Geurts</surname><given-names>J.J.G.</given-names></name></person-group><article-title>Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis</article-title><source>Brain</source><year>2020</year><volume>143</volume><fpage>150</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1093/brain/awz355</pub-id><pub-id pub-id-type="pmid">31730165</pub-id><pub-id pub-id-type="pmcid">PMC6938033</pub-id></element-citation></ref><ref id="B14-brainsci-14-00975"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koubiyr</surname><given-names>I.</given-names></name><name name-style="western"><surname>Deloire</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brochet</surname><given-names>B.</given-names></name><name name-style="western"><surname>Besson</surname><given-names>P.</given-names></name><name name-style="western"><surname>Charré-Morin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Saubusse</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tourdias</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ruet</surname><given-names>A.</given-names></name></person-group><article-title>Structural constraints of functional connectivity drive cognitive impairment in the early stages of multiple sclerosis</article-title><source>Mult. Scler.</source><year>2021</year><volume>27</volume><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1177/1352458520971807</pub-id><pub-id pub-id-type="pmid">33283582</pub-id></element-citation></ref><ref id="B15-brainsci-14-00975"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cortese</surname><given-names>R.</given-names></name><name name-style="western"><surname>De Stefano</surname><given-names>N.</given-names></name><name name-style="western"><surname>Giorgio</surname><given-names>A.</given-names></name></person-group><article-title>Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis</article-title><source>Front. Neurol.</source><year>2021</year><volume>12</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3389/fneur.2021.671894</pub-id><pub-id pub-id-type="pmcid">PMC8297166</pub-id><pub-id pub-id-type="pmid">34305785</pub-id></element-citation></ref><ref id="B16-brainsci-14-00975"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salazar</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Lincoln</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Karmonik</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rajab</surname><given-names>H.</given-names></name><name name-style="western"><surname>Helekar</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Khavari</surname><given-names>R.</given-names></name></person-group><article-title>Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: A randomized controlled trial protocol</article-title><source>BMC Urol.</source><year>2024</year><volume>24</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1186/s12894-023-01358-8</pub-id><pub-id pub-id-type="pmid">38273296</pub-id><pub-id pub-id-type="pmcid">PMC10809615</pub-id></element-citation></ref><ref id="B17-brainsci-14-00975"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tadic</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>D.</given-names></name><name name-style="western"><surname>Murrin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>W.</given-names></name><name name-style="western"><surname>Aizenstein</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Resnick</surname><given-names>N.M.</given-names></name></person-group><article-title>Brain Activity During Bladder Filling Is Related To White Matter Structural Changes in Older Women with Urinary Incontinence</article-title><source>Neuroimage</source><year>2010</year><volume>51</volume><fpage>1294</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.03.016</pub-id><pub-id pub-id-type="pmid">20302947</pub-id><pub-id pub-id-type="pmcid">PMC2880617</pub-id></element-citation></ref><ref id="B18-brainsci-14-00975"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuchel</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Moscufo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Guttmann</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Zeevi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wakefield</surname><given-names>D.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>J.</given-names></name><name name-style="western"><surname>DuBeau</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Wolfson</surname><given-names>L.</given-names></name></person-group><article-title>Localization of Brain White Matter Hyperintensities and Urinary Incontinence in Community-Dwelling Older Adults</article-title><source>J. Gerontol. Ser. A Biol. Sci. Med. Sci.</source><year>2009</year><volume>64</volume><fpage>902</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1093/gerona/glp037</pub-id><pub-id pub-id-type="pmid">19386575</pub-id><pub-id pub-id-type="pmcid">PMC2709544</pub-id></element-citation></ref><ref id="B19-brainsci-14-00975"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Principles of Diffusion Tensor Imaging and Its Applications to Basic Neuroscience Research</article-title><source>Neuron</source><year>2006</year><volume>51</volume><fpage>527</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.08.012</pub-id><pub-id pub-id-type="pmid">16950152</pub-id></element-citation></ref><ref id="B20-brainsci-14-00975"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newcombe</surname><given-names>V.F.J.</given-names></name><name name-style="western"><surname>Das</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cross</surname><given-names>J.J.</given-names></name></person-group><article-title>Diffusion imaging in neurological disease</article-title><source>J. Neurol.</source><year>2013</year><volume>260</volume><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1007/s00415-012-6769-y</pub-id><pub-id pub-id-type="pmid">23212757</pub-id></element-citation></ref><ref id="B21-brainsci-14-00975"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alotaibi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Podlasek</surname><given-names>A.</given-names></name><name name-style="western"><surname>AlTokhis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aldhebaib</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dineen</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Constantinescu</surname><given-names>C.S.</given-names></name></person-group><article-title>Investigating microstructural changes in white matter in multiple sclerosis: A systematic review and meta-analysis of neurite orientation dispersion and density imaging</article-title><source>Brain Sci.</source><year>2021</year><volume>11</volume><elocation-id>1151</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci11091151</pub-id><pub-id pub-id-type="pmid">34573172</pub-id><pub-id pub-id-type="pmcid">PMC8469792</pub-id></element-citation></ref><ref id="B22-brainsci-14-00975"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S.-H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.-J.</given-names></name></person-group><article-title>Quantitative evaluation of callosal abnormalities in relapsing-remitting multiple sclerosis using diffusion tensor imaging: A systemic review and meta-analysis</article-title><source>Clin. Neurol. Neurosurg.</source><year>2021</year><volume>201</volume><fpage>106442</fpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2020.106442</pub-id><pub-id pub-id-type="pmid">33373835</pub-id></element-citation></ref><ref id="B23-brainsci-14-00975"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sampedro</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kulisevsky</surname><given-names>J.</given-names></name></person-group><article-title>Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: A review</article-title><source>J. Neuroimaging</source><year>2022</year><volume>32</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/jon.12930</pub-id><pub-id pub-id-type="pmid">34506674</pub-id></element-citation></ref><ref id="B24-brainsci-14-00975"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basser</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Pierpaoli</surname><given-names>C.</given-names></name></person-group><article-title>Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI</article-title><source>J. Magn. Reson. B</source><year>1996</year><volume>111</volume><fpage>209</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1006/jmrb.1996.0086</pub-id><pub-id pub-id-type="pmid">8661285</pub-id></element-citation></ref><ref id="B25-brainsci-14-00975"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Enzinger</surname><given-names>C.</given-names></name><name name-style="western"><surname>Barkhof</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ciccarelli</surname><given-names>O.</given-names></name><name name-style="western"><surname>Filippi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kappos</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rocca</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ropele</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rovira</surname><given-names>À.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>T.</given-names></name><name name-style="western"><surname>de Stefano</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Nonconventional MRI and microstructural cerebral changes in multiple sclerosis</article-title><source>Nat. Rev. Neurol.</source><year>2015</year><volume>11</volume><fpage>676</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2015.194</pub-id><pub-id pub-id-type="pmid">26526531</pub-id></element-citation></ref><ref id="B26-brainsci-14-00975"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mallik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Samson</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Wheeler-Kingshott</surname><given-names>C.A.M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D.H.</given-names></name></person-group><article-title>Imaging outcomes for trials of remyelination in multiple sclerosis</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2014</year><volume>85</volume><fpage>1396</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2014-307650</pub-id><pub-id pub-id-type="pmid">24769473</pub-id><pub-id pub-id-type="pmcid">PMC4335693</pub-id></element-citation></ref><ref id="B27-brainsci-14-00975"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maekawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hagiwara</surname><given-names>A.</given-names></name><name name-style="western"><surname>Goto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Takemura</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andica</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kamagata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Cohen-Adad</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Advanced Diffusion MR Imaging for Multiple Sclerosis in the Brain and Spinal Cord</article-title><source>Magn. Reson. Med. Sci.</source><year>2022</year><volume>21</volume><fpage>58</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.2463/mrms.rev.2021-0091</pub-id><pub-id pub-id-type="pmid">35173096</pub-id><pub-id pub-id-type="pmcid">PMC9199983</pub-id></element-citation></ref><ref id="B28-brainsci-14-00975"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polman</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Reingold</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Banwell</surname><given-names>B.</given-names></name><name name-style="western"><surname>Clanet</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Filippi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fujihara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Havrdova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hutchinson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kappos</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria</article-title><source>Ann. Neurol.</source><year>2011</year><volume>69</volume><fpage>292</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1002/ana.22366</pub-id><pub-id pub-id-type="pmid">21387374</pub-id><pub-id pub-id-type="pmcid">PMC3084507</pub-id></element-citation></ref><ref id="B29-brainsci-14-00975"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pangman</surname><given-names>V.C.</given-names></name><name name-style="western"><surname>Sloan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Guse</surname><given-names>L.</given-names></name></person-group><article-title>An examination of psychometric properties of the Mini-Mental State Examination and the standardized Mini-Mental State Examination: Implications for clinical practice</article-title><source>Appl. Nurs. Res.</source><year>2000</year><volume>13</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1053/apnr.2000.9231</pub-id><pub-id pub-id-type="pmid">11078787</pub-id></element-citation></ref><ref id="B30-brainsci-14-00975"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurtzke</surname><given-names>J.F.</given-names></name></person-group><article-title>Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)</article-title><source>Neurology</source><year>1983</year><volume>33</volume><fpage>1444</fpage><pub-id pub-id-type="doi">10.1212/WNL.33.11.1444</pub-id><pub-id pub-id-type="pmid">6685237</pub-id></element-citation></ref><ref id="B31-brainsci-14-00975"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Banwell</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Barkhof</surname><given-names>F.</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Coetzee</surname><given-names>T.</given-names></name><name name-style="western"><surname>Comi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Correale</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fazekas</surname><given-names>F.</given-names></name><name name-style="western"><surname>Filippi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>M.S.</given-names></name><etal/></person-group><article-title>Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria</article-title><source>Lancet Neurol.</source><year>2018</year><volume>17</volume><fpage>162</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(17)30470-2</pub-id><pub-id pub-id-type="pmid">29275977</pub-id></element-citation></ref><ref id="B32-brainsci-14-00975"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haab</surname><given-names>F.</given-names></name><name name-style="western"><surname>Richard</surname><given-names>F.</given-names></name><name name-style="western"><surname>Amarenco</surname><given-names>G.</given-names></name><name name-style="western"><surname>Coloby</surname><given-names>P.</given-names></name><name name-style="western"><surname>Arnould</surname><given-names>B.</given-names></name><name name-style="western"><surname>Benmedjahed</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guillemin</surname><given-names>I.</given-names></name><name name-style="western"><surname>Grise</surname><given-names>P.</given-names></name></person-group><article-title>Comprehensive Evaluation of Bladder and Urethral Dysfunction Symptoms: Development and Psychometric Validation of the Urinary Symptom Profile (USP) Questionnaire</article-title><source>Urology</source><year>2008</year><volume>71</volume><fpage>646</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2007.11.100</pub-id><pub-id pub-id-type="pmid">18313122</pub-id></element-citation></ref><ref id="B33-brainsci-14-00975"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersson</surname><given-names>J.L.R.</given-names></name><name name-style="western"><surname>Sotiropoulos</surname><given-names>S.N.</given-names></name></person-group><article-title>An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging</article-title><source>Neuroimage</source><year>2016</year><volume>125</volume><fpage>1063</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.10.019</pub-id><pub-id pub-id-type="pmid">26481672</pub-id><pub-id pub-id-type="pmcid">PMC4692656</pub-id></element-citation></ref><ref id="B34-brainsci-14-00975"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melbourne</surname><given-names>A.</given-names></name><name name-style="western"><surname>Toussaint</surname><given-names>N.</given-names></name><name name-style="western"><surname>Owen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>I.</given-names></name><name name-style="western"><surname>Anthopoulos</surname><given-names>T.</given-names></name><name name-style="western"><surname>De Vita</surname><given-names>E.</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ourselin</surname><given-names>S.</given-names></name></person-group><article-title>NiftyFit: A Software Package for Multi-parametric Model-Fitting of 4D Magnetic Resonance Imaging Data</article-title><source>Neuroinformatics</source><year>2016</year><volume>14</volume><fpage>319</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1007/s12021-016-9297-6</pub-id><pub-id pub-id-type="pmid">26972806</pub-id><pub-id pub-id-type="pmcid">PMC4896995</pub-id></element-citation></ref><ref id="B35-brainsci-14-00975"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickman</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Barker</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Molyneux</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D.H.</given-names></name></person-group><article-title>Technical note: The comparison of hypointense lesions from ‘pseudo-T1’ and T1-weighted images in secondary progressive multiple sclerosis</article-title><source>Mult. Scler.</source><year>2002</year><volume>8</volume><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1191/1352458502ms824xx</pub-id><pub-id pub-id-type="pmid">12356212</pub-id></element-citation></ref><ref id="B36-brainsci-14-00975"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Oishi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Faria</surname><given-names>A.V.</given-names></name></person-group><article-title>White matter atlases based on diffusion tensor imaging</article-title><source>Curr. Opin. Neurol.</source><year>2009</year><volume>22</volume><fpage>362</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1097/WCO.0b013e32832d954b</pub-id><pub-id pub-id-type="pmid">19571751</pub-id><pub-id pub-id-type="pmcid">PMC2883814</pub-id></element-citation></ref><ref id="B37-brainsci-14-00975"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakana</surname><given-names>S.</given-names></name><name name-style="western"><surname>Caprihan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Panzenboeck</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Fallon</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Perry</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gollub</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dubey</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Reproducibility of quantitative tractography methods applied to cerebral white matter</article-title><source>Neuroimage</source><year>2007</year><volume>36</volume><fpage>630</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.02.049</pub-id><pub-id pub-id-type="pmid">17481925</pub-id><pub-id pub-id-type="pmcid">PMC2350213</pub-id></element-citation></ref><ref id="B38-brainsci-14-00975"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>T.E.</given-names></name></person-group><article-title>Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference</article-title><source>Neuroimage</source><year>2009</year><volume>44</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.03.061</pub-id><pub-id pub-id-type="pmid">18501637</pub-id></element-citation></ref><ref id="B39-brainsci-14-00975"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudre</surname><given-names>C.</given-names></name><name name-style="western"><surname>Anson</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Davagnanam</surname><given-names>I.</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mendelson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Prados</surname><given-names>F.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>L.</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Bullseye’s representation of cerebral white matter hyperintensities</article-title><source>J. Neuroradiol.</source><year>2018</year><volume>45</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.neurad.2017.10.001</pub-id><pub-id pub-id-type="pmid">29132940</pub-id><pub-id pub-id-type="pmcid">PMC5867449</pub-id></element-citation></ref><ref id="B40-brainsci-14-00975"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardoso</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Modat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wolz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Melbourne</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cash</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rueckert</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ourselin</surname><given-names>S.</given-names></name></person-group><article-title>Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion</article-title><source>IEEE Trans. Med. Imaging</source><year>2015</year><volume>34</volume><fpage>1976</fpage><lpage>1988</lpage><pub-id pub-id-type="doi">10.1109/TMI.2015.2418298</pub-id><pub-id pub-id-type="pmid">25879909</pub-id></element-citation></ref><ref id="B41-brainsci-14-00975"><label>41.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Yezzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>J.L.</given-names></name></person-group><article-title>A PDE Approach for Thickness, Correspondence, and Gridding of Annular Tissues</article-title><source>Computer Vision—ECCV 2002</source><person-group person-group-type="editor"><name name-style="western"><surname>Heyden</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sparr</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>P.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2002</year><fpage>575</fpage><lpage>589</lpage></element-citation></ref><ref id="B42-brainsci-14-00975"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stritt</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bohner</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ortlieb</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ochs</surname><given-names>V.</given-names></name><name name-style="western"><surname>Grilo</surname><given-names>N.</given-names></name></person-group><article-title>Relationship between MRI Findings and Urodynamic Parameters in Patients with Multiple Sclerosis: Prediction of Upper Urinary Tract Damage?</article-title><source>Sclerosis</source><year>2023</year><volume>1</volume><fpage>124</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.3390/sclerosis1030013</pub-id></element-citation></ref><ref id="B43-brainsci-14-00975"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Reddel</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Chataway</surname><given-names>J.</given-names></name><name name-style="western"><surname>Riminton</surname><given-names>S.</given-names></name><name name-style="western"><surname>Barnett</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Masters</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barnett</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>T.A.</given-names></name></person-group><article-title>The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2015</year><volume>86</volume><fpage>1374</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2014-309649</pub-id><pub-id pub-id-type="pmid">25857658</pub-id></element-citation></ref><ref id="B44-brainsci-14-00975"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akkoç</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bardak</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Yıldız</surname><given-names>N.</given-names></name><name name-style="western"><surname>Özlü</surname><given-names>A.</given-names></name><name name-style="western"><surname>Erhan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yürü</surname><given-names>B.</given-names></name><name name-style="western"><surname>Öztekin</surname><given-names>S.N.S.</given-names></name><name name-style="western"><surname>Türkoğlu</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Paker</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yumuşakhuylu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis: Running head: OAB-V8, BICAMS and HAD scale in MS</article-title><source>Mult. Scler. Relat. Disord.</source><year>2023</year><volume>70</volume><fpage>104476</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2022.104476</pub-id><pub-id pub-id-type="pmid">36603290</pub-id></element-citation></ref><ref id="B45-brainsci-14-00975"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrew</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nathan</surname><given-names>P.W.</given-names></name></person-group><article-title>Lesions on the anterior frontal lobes and disturbances of micturition and defaecation</article-title><source>Brain</source><year>1964</year><volume>87</volume><fpage>233</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1093/brain/87.2.233</pub-id><pub-id pub-id-type="pmid">14188274</pub-id></element-citation></ref><ref id="B46-brainsci-14-00975"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazeaud</surname><given-names>C.</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Braun</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hossu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Khavari</surname><given-names>R.</given-names></name></person-group><article-title>Functional MRI in neuro-urology: A narrative review</article-title><source>Prog. Urol.</source><year>2023</year><volume>33</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.purol.2023.03.002</pub-id><pub-id pub-id-type="pmid">37062631</pub-id></element-citation></ref><ref id="B47-brainsci-14-00975"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffiths</surname><given-names>D.</given-names></name><name name-style="western"><surname>Derbyshire</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stenger</surname><given-names>A.</given-names></name><name name-style="western"><surname>Resnick</surname><given-names>N.</given-names></name></person-group><article-title>Brain control of normal and overactive bladder</article-title><source>J. Urol.</source><year>2005</year><volume>174</volume><fpage>1862</fpage><lpage>1867</lpage><pub-id pub-id-type="doi">10.1097/01.ju.0000177450.34451.97</pub-id><pub-id pub-id-type="pmid">16217325</pub-id></element-citation></ref><ref id="B48-brainsci-14-00975"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhtz-Buschbeck</surname><given-names>J.</given-names></name><name name-style="western"><surname>van der Horst</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>S.</given-names></name><name name-style="western"><surname>Filippow</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>O.</given-names></name><name name-style="western"><surname>Braun</surname><given-names>P.</given-names></name></person-group><article-title>Activation of the supplementary motor area (SMA) during voluntary pelvic floor muscle contractions-An fMRI study</article-title><source>Neuroimage</source><year>2007</year><volume>35</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.12.032</pub-id><pub-id pub-id-type="pmid">17293127</pub-id></element-citation></ref><ref id="B49-brainsci-14-00975"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Critchley</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Wiens</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rotshtein</surname><given-names>P.</given-names></name><name name-style="western"><surname>Öhman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dolan</surname><given-names>R.J.</given-names></name></person-group><article-title>Neural systems supporting interoceptive awareness</article-title><source>Nat. Neurosci.</source><year>2004</year><volume>7</volume><fpage>189</fpage><pub-id pub-id-type="doi">10.1038/nn1176</pub-id><pub-id pub-id-type="pmid">14730305</pub-id></element-citation></ref><ref id="B50-brainsci-14-00975"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contreras-Rodríguez</surname><given-names>O.</given-names></name><name name-style="western"><surname>Cano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vilar-López</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rio-Valle</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Verdejo-Román</surname><given-names>J.</given-names></name><name name-style="western"><surname>Navas</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Martín-Pérez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fernández-Aranda</surname><given-names>F.</given-names></name><name name-style="western"><surname>Menchón</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Soriano-Mas</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Visceral adiposity and insular networks: Associations with food craving</article-title><source>Int. J. Obes.</source><year>2019</year><volume>43</volume><fpage>503</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/s41366-018-0173-3</pub-id><pub-id pub-id-type="pmid">30120426</pub-id></element-citation></ref><ref id="B51-brainsci-14-00975"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roseborough</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>L.</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>M.</given-names></name><name name-style="western"><surname>E Cipriano</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hachinski</surname><given-names>V.C.</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>S.N.</given-names></name></person-group><article-title>White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta-analysis, systematic review, and recommendations for future study harmonization</article-title><source>Alzheimers Dement.</source><year>2023</year><volume>19</volume><fpage>194</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1002/alz.12642</pub-id><pub-id pub-id-type="pmid">35319162</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="brainsci-14-00975-f001" orientation="portrait"><label>Figure 1</label><caption><p>WM skeleton and significant results from TBSS. The WM skeleton in green is created based on voxels indicative of WM across pwMS (n = 26). (<bold>a</bold>): Voxels in red are indicative of a significant FA reduction in MS-OAB compared to MS-no-LUTS, adjusting for age and EDSS (<italic toggle="yes">p</italic> = 0.072). (<bold>b</bold>): Voxels in red show significant negative correlation between FA and USP-OAB sub-score (<italic toggle="yes">p</italic> = 0.021) in the following tracts: ACR: anterior corona radiata; ATR: anterior thalamic radiation; CC: corpus callosum; IFOF: inferior fronto-occipital fasciculus; ILF: inferior longitudinal fasciculus; R: right-sided; SCR: superior corona radiata; SLF: superior longitudinal fasciculus.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="brainsci-14-00975-g001.jpg"/></fig><fig position="float" id="brainsci-14-00975-f002" orientation="portrait"><label>Figure 2</label><caption><p>Frequency plots of lesion volume in terms of median and IQR in (<bold>a</bold>) MS-no-LUTS and (<bold>b</bold>) MS-OAB. The frequency plots were drawn as the ratio between number of significant voxels in a given region and volume of this region. The plots are considered radially between the ventricles and the cortical grey matter discretized into four equidistant layers, derived from the solution to the Laplace equation [<xref rid="B41-brainsci-14-00975" ref-type="bibr">41</xref>]. The colour bars from bottom to top indicate the lesion volume from lowest to highest. IQR: interquartile range. Frontal: frontal lobe; Occipital: occipital lobe; Parietal: parietal lobe; Subcortical Infratentorial: the basal ganglia, thalami, and infratentorial regions from both sides; Temporal: temporal lobe.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="brainsci-14-00975-g002.jpg"/></fig><fig position="float" id="brainsci-14-00975-f003" orientation="portrait"><label>Figure 3</label><caption><p>Bullseye plots showing significant results from TBSS. (<bold>a</bold>) Bullseye plots showing reduced FA in MS-OAB, compared with MS-no-LUTS, adjusting for age and EDSS (<italic toggle="yes">p</italic> = 0.072). (<bold>b</bold>) Bullseye plots showing negative correlation between FA and USP-OAB sub-score across pwMS (n = 26, <italic toggle="yes">p</italic> = 0.021). The distribution plots reflect the ratio between the number of voxels of interest (significant values) located in the specific region and the overall number of significant voxels, while the frequency plots are drawn as the ratio between number of significant voxels in a given region and volume of this region. The plots are considered radially between the ventricles and the cortical grey matter discretized into four equidistant layers, derived from the solution to the Laplace equation [<xref rid="B41-brainsci-14-00975" ref-type="bibr">41</xref>]. The colour bars from bottom to top indicate the number of voxels from lowest to highest at the significance level. FRONT: frontal lobe; BG: the basal ganglia, thalami, and infratentorial regions from both sides; OCC: occipital lobe; PAR: parietal lobe; TEMP: temporal lobe.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="brainsci-14-00975-g003.jpg"/></fig><table-wrap position="float" id="brainsci-14-00975-t001" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic characteristics of healthy controls and pwMS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HCs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pwMS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MS-no-LUTS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MS-OAB</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">n</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>b</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mean age, years (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">48.5 (20.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.3 (9.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">37.5 (8.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">46.1 (8.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.641 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.026 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mean EDSS (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 (1.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9 (0.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.9 (2.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.004 <sup>b,</sup>**</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Median lesion volume, ×10<sup>3</sup> mL (range)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7 (0.2–69.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9 (0.2–13.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.8 (1.0–69.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.055 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Median disease duration, years (range)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0 (0.8–42.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (1.0–14.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.3 (0.8–42.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.029 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean USP-OAB (SD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 (1.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.9 (4.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0 (1.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8 (3.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001 <sup>a,</sup>**</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001 <sup>b,</sup>**</td></tr></tbody></table><table-wrap-foot><fn><p>EDSS: Expanded Disability Status Scale; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; OAB: overactive bladder; pwMS: patients with MS; USP: Urinary Symptom Profile; USP-OAB: USP OAB sub-score. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Chi Square test, student’s <italic toggle="yes">t</italic>-test, and Mann–Whitney U test. <sup>a</sup>: statistical difference between HCs and pwMS; <sup>b</sup>: statistical difference between MS-no-LUTS and MS-OAB. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="brainsci-14-00975-t002" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t002_Table 2</object-id><label>Table 2</label><caption><p>FA values of mean skeleton in HCs, pwMS, and pwMS sub-groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FA of Mean Skeleton<break/>(Median, Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for Age)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for EDSS)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for Age + EDSS)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCs (n = 14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4590268<break/>(0.4404533, 0.4853403)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.004 **</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N/A</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pwMS (n = 29)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4338049<break/>(0.3303200, 0.4874299)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MS-no-LUTS (n = 9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4446728<break/>(0.4288627, 0.4740112)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.159</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.047 *</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.072</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS-OAB (n = 17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4299469<break/>(0.3305743, 0.4859033)</td></tr></tbody></table><table-wrap-foot><fn><p>FA: fractional anisotropy; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; pwMS: patients with MS. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Mann–Whitney U test. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="brainsci-14-00975-t003" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t003_Table 3</object-id><label>Table 3</label><caption><p>Correlations between FA values and clinical scores.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EDSS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">USP-OAB</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FA of mean skeleton of all subjects (n = 43)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.36 *<break/><italic toggle="yes">p</italic> = 0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.493 **<break/><italic toggle="yes">p</italic> = 0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FA of mean skeleton of pwMS (n = 26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.51 **<break/><italic toggle="yes">p</italic> = 0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.271<break/><italic toggle="yes">p</italic> = 0.181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.449 *<break/><italic toggle="yes">p</italic> = 0.021</td></tr></tbody></table><table-wrap-foot><fn><p>Spearman’s correlations between FA value and age; EDSS and USP-OAB sub-score were tested in HCs and pwMS. EDSS: Expanded Disability Status Scale; FA: fractional anisotropy; MS: multiple sclerosis; N/A: not applicable; <italic toggle="yes">p</italic>: <italic toggle="yes">p</italic>-value of correlation; pwMS: patients with MS; r: Spearman’s correlation coefficient (two-tailed); USP-OAB: Urinary Symptom Profile OAB sub-score. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap></floats-group></article>